LRRK2 and Parkinson’s disease: from genetics to targeted therapy.

Sosero YL and Gan-Or Z. LRRK2 and Parkinson’s disease: from genetics to targeted therapy. Annals of Clinical and Translationa Neurology. 2023. PubMed